The WHO approves lenacapavir every six months as a new step in HIV prevention, simplifying diagnoses and expanding ...

When the U.S. Congress passed the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act in August 1990, it honored a ...

The WHO issued guidance on long-acting lenacapavir and RDTs to support HIV PrEP implementation and simplified testing ...

A once-daily oral combination therapy for HIV — bictegravir plus lenacapavir — is more effective than complex regimens are, according to results from a phase 2 study of people with HIV who are ...

The discovery of broadly neutralizing antibodies (bNAbs) like b12 in 1994 marked a turning point in HIV research. B12 ...

HIV has been in retreat around the world. But with cuts to foreign aid, it's less clear where the trend lines go from here. NPR's Ari Shapiro talks to author Emily Bass about the future of the virus.

LONDON--(BUSINESS WIRE)--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced the presentation of abstracts from its ...

Researchers at the German Center for Infection Research (DZIF) at Heidelberg University Hospital have decoded a previously ...

The United States has suspended some funding for its flagship AIDS relief program, according to international organizations and members of Congress who warn the cuts are already hurting patients and ...

KUALA LUMPUR, Malaysia — The World Health Organization has unveiled its much-anticipated new HIV treatment guidelines. Officials say the new approach will prevent 3 million deaths by 2025 and will ...

In a new Johns Hopkins Medicine-led study, researchers predict that ending federal funding for the Ryan White Program could ...